Search Results

A pilot study investigating the role of 18F‐FDG‐PET in the early identification of chemoradiotherapy response in anal cancer.

• Authors : Smith, Drew; Joon, Daryl Lim; Knight, Kellie

Subjects: ANAL cancer; CHEMORADIOTHERAPY; PILOT projects

• Source: Journal of Medical Radiation Sciences; Dec2022, Vol. 69 Issue 4, p439-447, 9p

Record details

Prognostic and predictive values of interim 18F-FDG PET during neoadjuvant chemoradiotherapy for esophageal cancer: a systematic review and meta-analysis.

• Authors : Han, Sangwon; Kim, Yong-il; Woo, Sungmin

• Source: Annals of Nuclear Medicine; Apr2021, Vol. 35 Issue 4, p447-457, 11p

Record details

Radiotherapy boost in patients with hypoxic lesions identified by 18F-FMISO PET/CT in non-small-cell lung carcinoma: can we expect a better survival outcome without toxicity? [RTEP5 long-term follow-up].

• Authors : Vera, Pierre (AUTHOR); Mihailescu, Sorina-Dana (AUTHOR); Lequesne, Justine (AUTHOR)

Subjects: TISSUE wounds; CANCER chemotherapy; RADIOTHERAPY

• Source: European Journal of Nuclear Medicine & Molecular Imaging. Jul2019, Vol. 46 Issue 7, p1448-1456. 9p. 1 Diagram, 2 Charts, 1 Graph.

Record details

Dynamic contrast-enhanced CT to assess metabolic response in patients with advanced non-small cell lung cancer and stable disease after chemotherapy or chemoradiotherapy.

• Authors : Hwang, Sung; Yoo, Mi; Park, Chul

Subjects: LUNG cancer; POSITRON emission tomography; TUMORS

• Source: European Radiology; Jun2013, Vol. 23 Issue 6, p1573-1581, 9p

Record details

Predictive value of quantitative 18F-FDG-PET radiomics analysis in patients with head and neck squamous cell carcinoma.

• Authors : Martens, Roland M.; Koopman, Thomas; Noij, Daniel P.

Subjects: SQUAMOUS cell carcinoma; FORECASTING; HEAD & neck cancer

• Source: EJNMMI Research; 9/7/2020, Vol. 10 Issue 1, pN.PAG-N.PAG, 1p

Record details

Abstracts_Sunday.

Subjects: PARKINSON'S disease; POSITRON emission tomography; HUNTINGTON disease

• Source: European Journal of Nuclear Medicine & Molecular Imaging. Oct2008 Supplement 2, Vol. 35, p127-153. 27p. 9 Charts.

Record details

PET imaging with [18F]3′-deoxy-3′-fluorothymidine for prediction of response to neoadjuvant treatment in patients with rectal cancer.

• Authors : Wieder, Hinrich A.; Geinitz, Hans; Rosenberg, Robert

Subjects: POSITRON emission tomography; MEDICAL imaging systems; RECTAL cancer

• Source: European Journal of Nuclear Medicine & Molecular Imaging. Jun2007, Vol. 34 Issue 6, p878-883. 6p. 1 Diagram, 1 Chart, 3 Graphs.

Record details

Prognostic value of gross tumor volume delineated by FDG-PET-CT based radiotherapy treatment planning in patients with locally advanced pancreatic cancer treated with chemoradiotherapy.

Subjects: TUMOR prognosis; POSITRON emission tomography; CANCER chemotherapy

• Source: Radiation Oncology; 2012, Vol. 7 Issue 1, p37-44, 8p, 4 Charts, 2 Graphs

Record details

Clinical Usefulness of [(18)F] Fluoro-2-Deoxy-d-Glucose Uptake in 178 Head-and-Neck Cancer Patients With Nodal Metastasis Treated With Definitive Chemoradiotherapy: Consideration of Its Prognostic Value and Ability to Provide Guidance for Optimal Selection of Patients for Planned Neck Dissection

• Authors : Inokuchi, Haruo¹ ; Kodaira, Takeshi¹; Tachibana, Hiroyuki¹

Subjects: *RADIOPHARMACEUTICALS; *POSITRON emission tomography; *TREATMENT effectiveness

• Source: International Journal of Radiation Oncology, Biology, Physics. Mar2011, Vol. 79 Issue 3, p747-755. 9p.

Record details

Pretreatment metabolic tumour volume and total lesion glycolysis are not independent prognosticators for locally advanced cervical cancer patients treated with chemoradiotherapy.

• Authors : Guler, Ozan Cem; Torun, Nese; Yildirim, Berna Akkus

Subjects: GLYCOLYSIS; CERVICAL cancer; CHEMORADIOTHERAPY

• Source: British Journal of Radiology; Apr2018, Vol. 91 Issue 1084, pN.PAG-N.PAG, 1p

Record details